2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. - Wikidata - awgldk - TriplyDB

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

http://www.wikidata.org/entity/Q38410159

about

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old.Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.School-based surveillance for influenza vaccine effectiveness during 2014-2015 seasons in Hong Kong.Potential Consequences of Not Using Live Attenuated Influenza Vaccine.Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States.Are children's vitamin D levels and BMI associated with antibody titers produced in response to 2014-2015 influenza vaccine?The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.Perspectives from the society for pediatric research (SPR): Decreased effectiveness of the live attenuated influenza vaccine (LAIV).Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.Influenza vaccination status and outcomes among influenza-associated hospitalizations in Columbus, Ohio (2012-2015).Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults.Immune responses after live attenuated influenza vaccination.An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness.Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.IL-15 enhances cross-reactive antibody recall responses to seasonal H3 influenza viruses in vitro.Early programming and late-acting checkpoints governing the development of CD4 T cell memory.Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines.Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.Pooling and the Potential Dilution of Repeat Influenza Vaccination Effects.Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.Editorial Commentary: Influenza Vaccine Effectiveness: A Glass Both Half Full and Half Empty.Clinical Expectations for Better Influenza Virus Vaccines-Perspectives from the Young Investigators' Point of View An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity A Review of DNA Vaccines Against Influenza Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study Estimating Vaccine-Driven Selection in Seasonal Influenza Reply to Chung et al

P2860

Q30151372-47A027F9-042A-4C64-8CF3-F0C28828FFA2 Q37311543-8B65779F-CC93-403E-8D22-EE49E98E84BA Q38614227-736602B8-6717-44BF-B1E7-292A44A8D3C1 Q38729177-08ABF7FC-A892-41DA-8C47-DA2B23E087A9 Q38818834-F279E7AF-618E-4673-A45D-7381CD747D9C Q38826017-EC0567E8-F99F-4A14-81F8-0BF264A2CCFC Q38957414-4CE702DF-7E75-4946-9931-E643237B80CD Q39340731-F67A301F-9611-41DC-9139-68673153BC03 Q40068128-23E40EB0-3E62-4F48-AE2D-6BCAF0489FB0 Q40089214-155F0C12-4D3A-438F-802F-1ECBCB1F6F74 Q40152643-CD78460D-6896-4EF6-9048-9EB1444DC113 Q40270568-8F15E739-344C-4280-BC13-D0F23AE72900 Q41919202-28AA4365-77E9-4020-A619-07A2F87868E0 Q41930762-1FBD52C9-6A62-4DDC-AD1C-F6AE1BBBB3CF Q47150783-85FD9007-FA5C-4A6C-BDF0-55B87228AF74 Q47612308-4742FF52-CF73-45D2-8D2A-82CEBD463492 Q47678684-E15DE8F2-7112-4009-AC50-37AB84E101E7 Q47692575-F6EAA281-FF10-4F2F-9DAA-BE0B59A32DF1 Q47937377-076E1BF6-041D-470E-8CB6-C67049251C70 Q49713969-83A801E4-F488-4AA5-9167-A5A7E5F9FF9E Q49989801-FD54EAAC-42E3-4438-B594-104BC4B99893 Q50044242-E38BD628-8E79-4568-9DB6-209595924531 Q50308620-D4602E5A-5714-4CFB-82A5-3D5A632C1171 Q50534689-AC6B61CE-6FA6-499C-87C7-35453791CAB6 Q52559511-AA32C333-B5E8-429B-B4EF-138B7A8C021D Q52627557-E5D63B20-D089-43D6-B378-D63FFDF00C40 Q52689551-9385194A-A0CC-46C0-8B00-2EE7E416209C Q53767227-C14FF5A9-1E3E-46A3-9AFC-06C415F7DDB3 Q54277492-4D97EF3D-C490-410E-80E2-0B438F70B4AF Q54513872-2DBC2351-43EF-4367-A661-25B4C4385549 Q56536297-2161B8AD-460E-4A61-BB7F-A53093055E12 Q57026121-A5F52573-ACEB-401D-A840-F1C0F1D165B2 Q57093953-B39FEAD9-DB2E-4909-845B-BB0DF165C09C Q57094261-57BED5FD-8F84-430A-87EC-3DC669BD9672 Q57100369-C5E484A5-012D-4361-9C90-393BCDB275B9 Q58722425-06172558-72CC-406B-8E28-C8957FD0AE59 Q58840617-694725B5-ECB7-47AE-8567-38FFA964765B

P2860

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

http://www.wikidata.org/entity/Q38410159

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

@en

type

label

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

@en

prefLabel

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

@en

P1433

Q38410159-A73385BB-C7B6-49EB-95ED-F9CC292C9606

P1476

Q38410159-E03E107E-B102-4709-882A-6DAD96150F63

P2093

Q38410159-03F2ED5B-A949-49C4-B2FE-2AADBC80BC00

Q38410159-315A9D6F-DBAD-4236-94B0-910FCC4991D8

Q38410159-46022245-A33B-4223-989C-E93DE3275365

Q38410159-4B1BFE72-D7C1-44D1-9091-6FB89CF32EBB

Q38410159-5CB8AA8F-866E-4BED-89E0-BEB53F12F196

Q38410159-6F3F05B7-39B4-4221-B319-40F84210763F

Q38410159-8C98D4AF-F83C-4FAD-AD03-00101CD79F96

Q38410159-CFC58349-80BB-4EF1-BF5A-0C8C14C83F73

Q38410159-D121B62C-1C86-43F5-8FB8-CC9A3D130CA3

Q38410159-DFA638F9-DC7F-4A1D-9297-1EC24A96AE5C

P2860

Q38410159-08FFC012-AC35-46EF-B53E-270755A22F70

Q38410159-29753E7A-CEFA-46F7-A565-8D9E58906596

Q38410159-3F0D7B5A-6764-444C-81D0-331A05CEF468

Q38410159-41E653F8-9278-4625-A172-895625736557

Q38410159-430E8F55-1370-4DBB-902B-867967C34848

Q38410159-45EFAE58-79A2-4286-B003-DA6027CF64E2

Q38410159-461672E5-1F4A-4A11-9844-203D71DAB310

Q38410159-4C89A02C-6380-4F16-915B-E6C19D07B7DB

Q38410159-589D5C6D-A45E-4DA0-8746-B56466E3E5D1

Q38410159-67CF7BEA-9C18-48EC-B528-07B389CDED1A

P304

Q38410159-D8CC65C6-5EEE-44E8-A4DA-A0E1CB00F180

P31

Q38410159-5B7E29C8-E725-44FC-AD41-5813989DE382

P356

Q38410159-5AA6C1D5-EE8C-4207-9569-2575B9A6F931

P407

Q38410159-6D17D52D-A606-43D7-BDE1-44F8BE4EDE2D

P433

Q38410159-9AE2EC81-C430-4C4E-9EBF-BCBE95A0BE9B

P478

Q38410159-72BA8738-57B5-4822-91FA-6A9A15DA5A2B

P50

Q38410159-240368D0-AB06-43ED-88DF-810185912786

Q38410159-80E78AC6-042B-4FF8-AE8F-F4FCF5635CA8

Q38410159-B4F9BE25-B788-447C-9120-964F7B9DFBB4

Q38410159-C16178F4-2E47-4934-9616-CDDA059C6ED3

Q38410159-E9AAC8AB-D313-49D8-BF16-CE55AB53A2BC

P577

Q38410159-BE87FAF9-41F7-4B65-AEB1-C6C94173C1DF

P698

Q38410159-7D4D73D1-AB29-44E4-851C-CD50995D862C

P932

Q38410159-F5EF4737-681F-4258-9527-CE2624FBEB5C

P356

P1433

Clinical Infectious Diseases

P1476

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

@en

P2093

Brendan Flannery

http://www.w3.org/2001/XMLSchema#string

Huong Q McLean

http://www.w3.org/2001/XMLSchema#string

Jessie Chung

http://www.w3.org/2001/XMLSchema#string

Joshua G Petrie

http://www.w3.org/2001/XMLSchema#string

Kempapura Murthy

http://www.w3.org/2001/XMLSchema#string

Lisa A Jackson

http://www.w3.org/2001/XMLSchema#string

Manjusha Gaglani

http://www.w3.org/2001/XMLSchema#string

Michael L Jackson

http://www.w3.org/2001/XMLSchema#string

U.S. Flu VE Investigators

http://www.w3.org/2001/XMLSchema#string

US Flu VE Investigators

http://www.w3.org/2001/XMLSchema#string

P2860

A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity.

Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.

The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.

Improving immunization rates at 18 months of age: implications for individual practices

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season

P304

1564-1573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIW635

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Richard Zimmerman

Edward A Belongia

Mary Patricia Nowalk

P577

2016-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27702768

http://www.w3.org/2001/XMLSchema#string

P932

5146719

http://www.w3.org/2001/XMLSchema#string